The application of balloon aortic valvuloplasty to elderly patients with severe aortic stenosis and a low ventricular ejection fraction is undefined. Balloon aortic valvuloplasty was performed in a subset of 28 patients with low left ventricular ejection fraction (37±11%), severe aortic stenosis, and a mean age of 79 5 years. After valvuloplasty, significant increases were seen in aortic valve area (from 0.5+±0.1 to 0.9+±0.2 cm'), aortic systolic pressure (from 120±12 to 135±22 mm Hg), and cardiac output (from 4.2±1.1 to 4.8±1.6 I1min) (p<0.01), and significant decreases were seen in transaortic pressure gradient (from 69 25 to 35±+15 mm Hg) and pulmonary capillary wedge pressure (from 24 + 9 to 20 7 mm Hg) (p<0.01). All patients had symptomatically improved at the time of discharge. Serial radionuclide ventriculography showed an increase in left ventricular ejection fraction from 37±11% before valvuloplasty to 44±14% within 48 hours after dilatation and to 49±13% at 3 months after dilatation. However, there was substantial heterogeneity of response. Thirteen patients (group A) showed progressive increases in left ventricular ejection fraction (from 34±11% to 49±15% to 58 11%, p<0.0001), whereas 15 patients (group B) showed no significant change in ejection fraction (from 41+10% to 40±13% to 41±10%, p=NS) over 3 months. There was no difference between these groups with respect to age, extent of coronary artery disease, history of myocardial infarction, and aortic valve area before and after valvuloplasty. However, peak systolic wall stress and left ventricular dimensions were higher in group B compared with group A. In conclusion, balloon aortic valvuloplasty may result in symptomatic improvement in patients with aortic stenosis and depressed left ventricular ejection fraction; some patients develop progressive increases in ejection fraction, whereas others fail to show improvement. (Circulation 1988;78:1181-1191 Standard therapy over the last 25 years for adult patients with symptomatic aortic ste- 
catheterization via the brachial or femoral approach in 27 patients and by antegrade left heart catheterization via the transseptal approach in one patient.
The technique of balloon aortic valvuloplasty has been previously described in detail.11 '2 Briefly, all patients underwent standard diagnostic right and left heart cardiac catheterization. Measurements were made of systemic arterial, left ventricular, pulmonary artery, and pulmonary capillary wedge pressures. Oxygen consumption was measured by a metabolic rate meter (Waters Instruments), and cardiac output was calculated by the method of Fick. 19 After completion of prevalvuloplasty hemodynamic measurements, the left heart catheter was exchanged for the balloon valvuloplasty catheter (Meditech, Watertown, Massachusetts). Th'ere was no evidence for a left-to-right shunt after valvuloplasty in the one patient who required transseptal catheterization.
The largest balloon size used for valve dilatation was a 12-mm balloon in one patient, an 18-mm balloon in one patient, a 20-mm balloon in 25 patients, and a 23-mm balloon in one patient. After dilatation, the balloon catheter was exchanged for the diagnostic left heart catheter, and repeat pressure measurements and determinations of Fick cardiac output were obtained. The gated blood pool scans were obtained with a 64 x 64 pixel matrix for the full field of view (250 cm). Thirty-two images were acquired per RR interval with a mobile Anger camera computer system (Technicare 410, Solon, Ohio) with on-board VIP computer system. Each study contained at least 10 million counts acquired over 3-5 minutes.
Data analysis. Global left ventricular ejection fraction was determined for all studies. The lowest limit for normal left ventricular ejection fraction in our center is 55%. Left ventricular volumes were determined with a geometric (planimetry) technique. 22 Briefly, left ventricular count rate (volume) versus time curves were obtained with an operator-drawn fixed left ventricular region of interest and a computergenerated background region of interest. Background was assumed to be constant both spatially and temporally. The operator identified the septal and the free wall borders of the left ventricle from the end-diastolic image, and the atrioventricular plane was identified from the stroke volume image. The surface area and long axis of the left ventricle were measured in the modified left anterior oblique view, and end-diastolic volume was calculated according to the area-length method.'9 The stroke volume ratio (SV ratio) was calculated as the ratio of the stroke volume of the left ventricle to the stroke volume of the right ventricle to provide an index of the severity of left-sided regurgitant lesions.
Echocardiographic Evaluation
Pulsed wave Doppler echocardiographic studies were performed 24 hours before, 48 hours after, and 3 months after valvuloplasty with an ATL Mark 600 combined imaging-Doppler echocardiograph. The presence or absence of aortic insufficiency was determined by inspection of the left ventricular outflow tract with parasternal long-and short-axis and apical four-chamber views. The presence of mitral regurgitation was determined by interrogation of the left atrium above the mitral leaflets with the parasternal and apical long-axis, four-chamber, and two-chamber views. The degree of mitral regurgitation was graded as none, trace, mild, moderate, or severe, depending on the level in the left atrium to which the Doppler signal was detected.23 M-mode cursor strips were obtained from the two-dimensional echocardiogram at the level of the chordae tendiniae and were used for the determination of left ventricular end-diastolic dimension, septal thickness, and posterior wall thickness.
Left Ventricular Wall Stress
Estimates of left ventricular wall stress were calculated by the formula:
Wallstrss= PR Wall stress = 2h (1 + h/2R) where R is half the end-diastolic dimension of the left ventricle, h is the posterior wall thickness, and P is pressure.24 Peak systolic wall stress and enddiastolic wall stress were calculated with left ventricular peak systolic pressure and end-diastolic pressure, respectively, obtained at catheterization immediately before and after dilatation. Echocar 
Complications
There were no procedure-related deaths or ems bolic events, and worsening aortic insufficiency did not occur in any patient. Transient complications included vasovagal reactions requiring atropine in two patients and left bundle branch block lasting less than 2 hours in two patients. Blood transfusions were required in seven patients because of blood loss during exchange of catheters. One patient with pulmonary edema required transient intubation but ultimately did well. Surgical repair of the femoral artery was required in five patients because of arteriovenous fistulae in three patients and pseudoaneurysm formation in two patients.
Symptomatic Improvement
Before balloon aortic valvuloplasty, all patients had symptomatic aortic stenosis, including 25 of 28 patients with New York Heart Association Class III or IV congestive heart failure. There were no inhospital deaths, and all patients were symptomatically improved at discharge. In particular, patients with congestive heart failure symptoms were in New York Heart Association Class I or II at discharge.
Serial Left Ventricular Ejection Fraction
For the group of 28 patients, left ventricular ejection fraction increased from 37 + 11% before to 44 + 14% after to 49 + 13% 3 months after dilatation (p<0.001, Figure 1 ). However, there was heterogeneity of response and two subgroups of patients were identified based on the pattern of response of left ventricular ejection fraction ( 20 patients in sinus rhythm (Table 3) . Left ventricular end-diastolic volumes were higher in group B compared with group A before valvuloplasty, within 48 hours after dilatation, and at 3 months (Figure 4 ), although these differences were not statistically significant. Patients in both groups showed decreases in end-diastolic volume immediately after valvuloplasty (group A, 207±74 to 180+59 ml; group B, 243 ± 64 to 200 ± 48 ml; p = NS). However, 3 months after dilatation, patients in group A showed a further decrease in end-diastolic volume (180+59 to 173±38 ml, p = NS), whereas patients in group B showed an increase in left ventricular volume toward baseline (200 + 48 to 209 ± 58 ml, p = NS). The enddiastolic volume at 3 months was not statistically different from the end-diastolic volume before dilatation in either group. The baseline stroke volume ratio was similar between both groups and did not change significantly immediately after balloon valvuloplasty or at 3 months.
Left Ventricular Wall Stress
Left ventricular peak systolic wall stress could be estimated in 24 of 28 patients and was significantly higher in group B compared with group A before dilatation (p<0.05) ( Figure 5 ). Left ventricular peak systolic stress decreased in both groups after dilatation, and, although peak systolic wall stress remained higher in group B compared with group A after dilatation, this difference was not statistically significant. End-diastolic wall stress was similar between both groups and did not change after valvuloplasty.
Left Ventricular Dimensions
Although echocardiography did not detect significant changes in left ventricular dimensions (Figure 6 ).
Valvular Regurgitation
The extent of aortic insufficiency and mitral regurgitation was estimated by Doppler echocardiography. New aortic insufficiency was detected after valvuloplasty in one patient in group A, but supravalvular aortography in this patient revealed only trace aortic insufficiency. New aortic insufficiency was not detected in any patient in group B.
The extent of Doppler-detectable mitral regurgitation was estimated on a grading scale of 0 to 4 ( Table 5 ). The mean grade of mitral regurgitation was similar between both groups before valvuloplasty. Mitral regurgitation tended to decrease after valvuloplasty in group A, although these changes were not statistically significant. There was no statistical difference between groups with regard to the mean grade of mitral regurgitation at 3 months. Follow and may be associated with a perioperative mortality of less than 1% in many cases. 30 The perioperative mortality may range from 1 0% to 25% in patients with severe left heart failure and depressed ejection fraction.6.9.30 Other high-risk groups include patients over the age of 70 years in whom perioperative mortality approaches 17% 30.3 and patients who require both aortic valve replacement and coronary bypass surgery, in whom the perioperative mortality may be twofold to fourfold more than the risk of isolated aortic valve replacement.3"1
The long-term benefits of aortic valve replacement for aortic stenosis are well established. Aftersurgery studies have demonstrated hemodynamic improvement,5-9 partial or complete regression of left ventricular hypertrophy,5.8, 10 and improvement in left ventricular function.5-9 Many patients with aortic stenosis and depressed left ventricular ejection fraction show a significant increase in ejection fraction 1-2 years after surgery. 5, 6, 9 However, a variety of clinical and hemodynamic factors may exert an adverse effect on long-term survival. Advanced age, poor functional class, history of myocardial infarction, and cardiac enlargement may all be associated with an adverse outcome. 32 Hemodynamic factors that may influence outcome include the presence of pulmonary hypertension, an abnormal relation between ejection frac-POST FIGURE 5. Plot of left ventricular peak systolic wvall stress before and after valvuloplasty. Solid 
Limitations of Study
There are several limitations of this study. First, the ideal assessment of left ventricular wall stress should include simultaneous determinations of left ventricular pressure and dimensions, and micromanometertipped catheters are preferable to fluid-filled catheters. However, many of our patients were critically ill and would not tolerate the added burdens of additional studies in the catheterization laboratory. In addition, peak systolic stress occurs in early systole when left ventricular dimensions are slightly smaller than the dimensions at end diastole. Furthermore, wall stress data based on single dimensions may be limited in patients with regional left ventricular dysfunction because of previous infarction. Accordingly, the wall stress data in this study should be considered an estimate and may be subject to significant errors.
Second, the role of balloon injury in preventing an increase in ejection fraction in group B has not been addressed by this study. Preliminary studies by Paulus et a135 have reported the development of global myocardial ischemia with depression of left ventricular function in some patients treated with balloon aortic valvuloplasty. Whereas direct balloonmediated injury or balloon-induced ischemia could explain the lack of a positive ejection fraction response in group B, we have no data to support or refute this possibility. The failure of ejection fraction to increase in group B could be explained by irreversible impairment in myocardial contractile function or to continued excessive wall stress.
Third, these findings cannot be taken as an endorsement of balloon valvuloplasty as initial therapy for all patients with aortic stenosis and clinical heart failure. Most surgical series in the literature reflect experience in the 1970s, and recent advances in cardiac anesthesia, surgery technique, inotropic drugs, and intra-aortic balloon counterpulsation may reduce mortality in these high-risk patients. In addition, whereas long-term follow-up data after aortic valve replacement are available, there are only limited data regarding long-term survival, left ventricular function, and the incidence of restenosis after balloon aortic valvuloplasty. Conclusions Balloon aortic valvuloplasty can be performed safely and with a high rate of symptomatic improvement in elderly patients with aortic stenosis and depressed left ventricular ejection fraction. Nearly half the patients developed progressive increases in left ventricular ejection fraction 3 months after valvuloplasty. Early improvement in ejection fraction may be secondary to afterload reduction, whereas progressive improvement may be because of increases in contractile function associated with regression of hypertrophy and/or relief of subendocardial ischemia. Other patients show no change in ejection fraction, despite similar improvement in aortic valve area. The failure to increase ejection fraction may be because of irreversible impairment in myocardial contractile function and/or to excessive wall stress.
